Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta

Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease

(2017) Fabio A. Zucca et al.   PROGRESS IN NEUROBIOLOGY

Iron and dopamine: a toxic couple

(2016) Dominic J. Hare et al.   BRAIN

Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited

(2016) Jason Langley et al.   HUMAN BRAIN MAPPING

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study

(2015) Ronald B. Postuma et al.   ANNALS OF NEUROLOGY

Disease-Modifying Drugs in Parkinson’s Disease

(2015) Ariane Park et al.   DRUGS

Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping

(2015) Naying He et al.   HUMAN BRAIN MAPPING

A multicontrast approach for comprehensive imaging of substantia nigra

(2015) Jason Langley et al.   NEUROIMAGE

Histologic validation of locus coeruleus MRI contrast in post-mortem tissue

(2015) Noam I. Keren et al.   NEUROIMAGE

Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study

(2013) Alex Iranzo et al.   LANCET NEUROLOGY

The current and projected economic burden of Parkinson's disease in the United States

(2013) Stacey L. Kowal et al.   MOVEMENT DISORDERS

Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies

(2013) Shinichiro Kitao et al.   NEURORADIOLOGY

Is R2* a New MRI Biomarker for the Progression of Parkinson’s Disease? A Longitudinal Follow-Up

(2013) Miguel Ulla et al.   PLoS One

Iron accumulation in Parkinson’s disease

(2012) Hideki Mochizuki et al.   JOURNAL OF NEURAL TRANSMISSION

High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease

(2011) Ashley K. Lotfipour et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Combined R2* and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease

(2011) Guangwei Du et al.   MOVEMENT DISORDERS

Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature

(2010) Patrice Péran et al.   BRAIN

Brain Iron Deposition and Sequence Characteristics in Parkinsonism

(2010) Maija Rossi et al.   INVESTIGATIVE RADIOLOGY

Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X-ray fluorescence

(2010) Karla Hopp et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

The relevance of iron in the pathogenesis of Parkinson’s disease

(2010) Jeswinder Sian-Hülsmann et al.   JOURNAL OF NEUROCHEMISTRY

Utility of susceptibility-weighted MRI in differentiating Parkinson’s disease and atypical parkinsonism

(2010) Deepak Gupta et al.   NEURORADIOLOGY

Iron and reactive oxygen species activity in parkinsonian substantia nigra

(2010) Anna Wypijewska et al.   PARKINSONISM & RELATED DISORDERS

Iron, the substantia nigra and related neurological disorders

(2008) Amanda M. Snyder et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Bayesian analysis of neuroimaging data in FSL

(2008) Mark W. Woolrich et al.   NEUROIMAGE

Midbrain iron content in early Parkinson disease: A potential biomarker of disease status

(2008) W. R. W. Martin et al.   NEUROLOGY